FidoCure is a translational precision-medicine service for canine cancer, developed by One Health Company and backed by a16z. It combines next-generation genomic sequencing of a dog's tumor at a CLIA-certified (human-grade) lab with tumor profiling and an AI-driven data platform to identify cancer-driving mutations, then recommends personalized… - View it on GitHub